Evidence map›Paper›PMID 29022161›Full record

ArticlePurinergic signalling2017

POM-1 inhibits P2 receptors and exhibits anti-inflammatory effects in macrophages.

Gabriela Pimenta-Dos-Reis, Eduardo José Lopes Torres, Paula Gabriela Quintana, Lincon Onorio Vidal, Bárbara Andréa Fortes Dos Santos, Chuan-Sheng Lin, Norton Heise, Pedro Muanis Persechini, Julieta Schachter

Open access · bronzeAbstract read
In one paragraph

Article in Purinergic signalling, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Gabriela Pimenta-Dos-ReisInstituto de Biofísica Carlos Chagas Filho da Universidade Federal de Rio de Janeiro, Rio de Janeiro, Brazil.
Eduardo José Lopes TorresLaboratório de Helmintologia Romero Lascasas Porto, Departamento de Microbiologia, Imunologia e Parasitologia. Faculdade de Ciências Médicas, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil.
Paula Gabriela QuintanaInstituto de Biofísica Carlos Chagas Filho da Universidade Federal de Rio de Janeiro, Rio de Janeiro, Brazil.
Lincon Onorio VidalInstituto de Biofísica Carlos Chagas Filho da Universidade Federal de Rio de Janeiro, Rio de Janeiro, Brazil.
Bárbara Andréa Fortes Dos SantosInstituto de Biofísica Carlos Chagas Filho da Universidade Federal de Rio de Janeiro, Rio de Janeiro, Brazil.
Chuan-Sheng LinMicrobiota Research Center, Chang Gung University, Taoyuan, Taiwan.
Norton HeiseInstituto de Biofísica Carlos Chagas Filho da Universidade Federal de Rio de Janeiro, Rio de Janeiro, Brazil.
Pedro Muanis PersechiniInstituto de Biofísica Carlos Chagas Filho da Universidade Federal de Rio de Janeiro, Rio de Janeiro, Brazil.
Julieta SchachterMicrobiota Research Center, Chang Gung University, Taoyuan, Taiwan. julischachter@gmail.com.
Universidade Federal do Rio de Janeiro · BRChang Gung University · TWUniversidade do Estado do Rio de Janeiro · BR

Funding

Conselho Nacional de Desenvolvimento Científico e Tecnológico 441790/2014-3
6 · The paper itself

Abstract

Extracellular nucleotides can modulate the immunological response by activating purinergic receptors (P2Rs) on the cell surface of macrophages, dendritic, and other immune cells. In particular, the activation of P2X7R can induce release of cytokines and cell death as well as the uptake of large molecules through the cell membrane by a mechanism still poorly understood. Polyoxotungstate-1 (POM-1) has been proposed as a potent inhibitor of ecto-nucleotidases, enzymes that hydrolyze extracellular nucleotides, regulating the activity of P2Rs. However, the potential impact of POM-1 on P2Rs has not been evaluated. Here, we used fluorescent dye uptake, cytoplasmic free Ca

Indexed as

Adenosine TriphosphatasesAnimalsMacrophagesMicePurinergic P2X Receptor AntagonistsReceptors, Purinergic P2X7Signal TransductionTungsten CompoundsAdenosine TriphosphatasesectoATPasePurinergic P2X Receptor AntagonistsReceptors, Purinergic P2X7Tungsten CompoundsATPInflammationMacrophagePOM-1Purinergic receptor

Identifiers

PMID29022161
PMCPMC5714851
OpenAlexW2763459954

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.